All In Biotech

Drug Trial Radar · NCT07620392

An Extension Study to Assess Long-Term Safety and Efficacy of Afimkibart in Participants With Rheumatoid Arthritis

An Extension Study to Evaluate the Long-term Safety and Efficacy of Afimkibart (RO7790121) in Patients With Rheumatoid Arthritis Who Participated in Previous Afimkibart Clinical Trials

Last checked: Nov 19, 2026Latest source record: Nov 17, 2026 (this record)Source: ClinicalTrials.govMethods & limitations

RecruitingPivotal-lookingRandomized with 120 participants. This is a heuristic, not a regulatory label.

Status

Recruiting

Enrollment

120

Planned (sponsor's estimate)

Start

Jun 3, 2026

Primary completion

Jul 8, 2033

Study completion Jul 8, 2033

Sponsor

Lead sponsor
Hoffmann-La RocheRoche (Genentech) (RHHBY)
Sponsor type
Industry
First posted
Jun 2, 2026

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 2
Allocation
Randomized
Model
Parallel
Masking
Quadruple (participant, care provider, investigator, outcomes assessor)
Primary purpose
Treatment
FDA-regulated drug
Yes
Who can join
All sexes, from 18 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

The study will evaluate the long-term safety and efficacy of Afimkibart (also known as RO7790121) in participants with moderate to severe Rheumatoid Arthritis (RA) who have an inadequate response or intolerance to tumor necrosis factor (TNF) and/or Janus kinase (JAK) inhibitors, and who were previously treated with Afimkibart.

Conditions

  • Rheumatoid Arthritis

Interventions

  • AfimkibartDrug

    Participants will receive Afimkibart as per the schedule mentioned in the protocol.

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Percentage of Participants With Adverse Events (AEs)Time frame: From Baseline up to 6 years

Locations

17 sites in 5 countries. Site status is shown where the registry gives one.

  • Arthritis and Rheumatic Disease Specialty Inc

    Tamarac, Florida · Recruiting

  • Accurate Clinical Research Inc.

    Lake Charles, Louisiana · Recruiting

  • Accurate Clinical Management LLC

    Houston, Texas · Recruiting

  • DM Clinical Research at Tomball

    Tomball, Texas · Recruiting

  • Rheumatic Disease Center

    Glendale, Wisconsin · Recruiting

  • Centro Medico Arsema

    CABA, Buenos Aires, Argentina · Recruiting

  • APRILLUS Asistencia e Investigacion

    Buenos Aires, Ciudad Autonoma Buenos Aires, Argentina · Recruiting

  • IPC MT Instituto de Pesquisas Clinicas do Mato Grosso

    Cuiab, Mato Grosso, Brazil · Recruiting

  • Centro Mineiro de Pesquisa - CMIP

    Juiz de Fora, Minas Gerais, Brazil · Recruiting

  • CEPIC - Centro Paulista de Investigao Clnica e Servios Mdicos

    São Paulo, São Paulo, Brazil · Recruiting

  • Nzoz Bif-Med

    Bytom, Poland · Recruiting

  • Centrum Kliniczno-Badawcze J. Brzezicki, B. Górnikiewicz-Brzezicka Lekarze Spó?ka Partne

    Elblag, Poland · Recruiting

  • Zespol Poradni Specjalistycznych REUMED filia nr 1 Wallenroda

    Lublin, Poland · Recruiting

  • Twoja Przychodnia NCM

    Nowa Sól, Poland · Recruiting

  • Reumatop Grzegorz Rozumek Karin Pistorius Spolka Jawna

    Wroclaw, Poland · Recruiting

  • Centrum Medyczne Reuma Park

    Warsaw, Masovian Voivodeship, Poland · Recruiting

  • Hospital Universitario Virgen Macarena

    Seville, Spain · Recruiting

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.